Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 14, 2024
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processingAndrés J Muñoz Martín, Ramón Lecumberri, Juan Carlos Souto, et al.
Molecular Cancer Therapeutics|July 2, 2014
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapyAna Custodio, Juan Moreno-Rubio, Jorge Aparicio, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimenCarlos Gómez-Martin, Antonio Sánchez, Antonio Irigoyen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2016
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsJavier Salvador, Jorge Aparicio, Francisco Javier Baron, et al.
Oncology|March 28, 2018
A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group StudyJorge Aparicio, Alfonso Sánchez-Muñoz, Josep Gumà, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 27, 2022
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)Jorge Aparicio, Anna C Virgili Manrique, Jaume Capdevila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE StudyCaiming Xu, Alessandro Mannucci, Francis Esposito, et al.
European Urology Oncology|November 11, 2023
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines OfficeJoost L Boormans, Richard Sylvester, Lynn Anson-Cartwright, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2024
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH studyAna María López Muñoz, Encarnación González Flores, Alberto Carral Maseda, et al.
The Oncologist|September 12, 2014
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter TrialCarlos Fernandez-Martos, Gina Brown, Rafael Estevan, et al.
Pageof 9